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Application of gene therapy to the renal graft has a powerful
potential to improve the outcome of kidney transplantation
and eliminate detrimental side effects associated with
systemic therapy, through local expression of
immunoregulatory or other protective molecules. However,
the search for the optimal vector is still ongoing. In this
study, we used a modified adenovirus that has an
Arg-Gly-Asp (RGD) motif inserted in the HI loop of the fiber
knob, as a successful strategy to transduce the renal graft.
Donor Lewis rat kidneys were infused via the renal artery
with a solution containing either a fiber-modified adenovirus
(AdTL-RGD) or an unmodified adenovirus (AdTL), or with
saline. Syngeneic recipients were killed after 3, 7 or 14 days.
Efficiency, selectivity, localization, time course of gene
expression and side effects were studied using biochemical
and immunohistological techniques. Enhanced gene
expression was achieved selectively in the transplanted
kidney by AdTL-RGD, when compared to AdTL. Transgene
expression lasted for at least 2 weeks. With the AdTL-RGD
vector, the transgene was abundantly expressed in the renal
interstitial fibroblasts. An increase in the number of cytotoxic
T lymphocytes accompanied the use of either vector, when
compared to saline. These data convincingly show enhanced
and selective gene transfer to the fibroblasts of transplanted
kidneys using an RGD-modified adenovirus, providing
a highly efficient vector system for future therapeutic
interventions.
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In humans, the ultimate survival of transplanted kidneys
depends largely on extensive immunosuppression. Despite
the development of various novel immunosuppressive
drugs,1 side effects associated with systemic immunosuppres-
sion, such as opportunistic infections and malignancies, are
still major drawbacks in renal transplantation. As a
consequence, these life-threatening side effects have to be
balanced with effectiveness of the immunosuppression regi-
mens. A promising new strategy to overcome these problems
is induction of local immunosuppression in the donor organ
by means of gene therapy. In addition, gene therapy
approaches could be used to suppress other serious
transplantation-related pathological processes, such as ische-
mia–reperfusion injury and fibrosis.
The transplanted kidney is a particularly appropriate
candidate for gene therapy because of its accessibility.
However, the lack of a highly efficient, selective and nontoxic
vector system has hampered the development of a clinically
applicable therapeutic strategy preventing renal transplant
failure. Among the nonviral and viral vector systems
currently available (reviewed in Van der Wouden et al.2),
the adenovirus has a privileged place, mostly because of its
potential to transduce a broad panel of cells. Moreover, when
used in the transplantation setting, the adenovirus has the
additional advantage of being able to infect several cell types
at low temperature, allowing pretransplantation gene transfer
to be carried out during the period of cold preservation.3
Adenovirus targets cells via binding of the fiber knob to the
Coxsackie adenovirus receptor (CAR). After binding, inter-
nalization is achieved through an interaction between an
Arg-Gly-Asp (RGD) motif present in the penton base of the
virus and cell surface integrins (mainly av-type). CAR
expression is scarce in human kidneys.4 Moreover, even in
species in which CAR is abundantly expressed in the kidney,
such as mouse or rat,4 efficiency of renal transduction
remains low. Recently, a number of strategies, aiming at
enhancing the infectivity of adenovirus through re-targeting
to CAR-independent pathways, have been developed.5,6
Among them, the recombinant insertion of an RGD motif
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into the fiber knob,7 leading to binding of the virus to
integrins, is particularly attractive for the setting of kidney
transplantation, because integrins are widely expressed within
the kidney.8 Besides the C-terminal end of the knob, which
was initially selected for insertion, the HI loop has emerged
as a suitable site for genetic modification. This region is
exposed on the exterior of the fiber knob, being accessible for
binding to cellular targets. Moreover, the HI loop allows for
insertion of relatively large sequences without affecting the
structural integrity of the knob trimer.9 Enhanced infectivity
can thus be achieved, as both CAR-dependent and CAR-
independent cell entry pathways can be employed.
In this study, we used a modified adenovirus that has an
RGD motif inserted in the HI loop of the fiber knob as a
successful strategy to enhance efficiency of adenovirus-
mediated gene delivery to the transplanted kidney. The
specific targeting of the interstitium, as achieved in our study,
is of particular relevance for transplanted kidneys, in which
the interstitium is the theatre of both rejection and fibrosis.
RESULTS
Viral titer optimization and time course of AdTL-RGD
expression
Preliminary experiments showed that both AdTL-RGD and
AdTL-delivered genes are optimally expressed between 48
and 72 h after infection. Initially, the optimal viral titer of
AdTL-RGD was sought, taking as criteria the transduction
efficiency and selectivity. The highest transduction of the
transplanted kidney, measured as luciferase activity at 72 h,
was found at a titer of 3 109 plaque-forming unit (PFU)
(Figure 1). Infusion of 0.8 109 PFU resulted in
1.68 10470.58 104 counts per second (c.p.s)/mg protein,
and 1.5 109 PFU yielded 1.61 10570.56 105 c.p.s/mg
protein. In the 3 109 PFU-infused kidneys, luciferase
activity was 4.91 10570.78 105 c.p.s./mg protein (30
times higher than with the lowest titer). When 6 109 PFU
was used, no further improvement in transduction efficiency
was achieved (4.41 10571.03 105 c.p.s./mg protein). The
saline-treated animals were negative for luciferase activity.
Tissue distribution of AdTL-RGD, measured as luciferase
activity at 72 h in various organs, showed a similar pattern in
all the infected animals. All organs studied were devoid of
luciferase, except for the liver and spleen, in which very low,
although dose-dependent, levels of luciferase activity were
detected (Figure 1). As the 3 109 PFU yielded the highest
and still graft-targeted transgene expression, this viral titer
was considered as optimal and used to study the time course
of the transgene expression. The transplanted kidney showed
the highest luciferase activity at day 3, decreasing over time to
day 14 after transplantation (Figure 2). All the other organs
were negative for luciferase at both days 7 and 14 (data not
shown).
Enhanced delivery of the transgene through AdTL-RGD
compared to AdTL
The infection efficiency and selectivity of AdTL-RGD was
compared with that of an adenovirus that lacks the RGD
modification in the fiber. At 72 h after transplantation, AdTL
yielded, in the transplanted kidney, less than 20% of the
luciferase activity obtained with AdTL-RGD (Figure 3).
Infection of the transplanted kidney with AdTL did not result
in expression in all the other organs, except for the liver and
the spleen, which exhibited very low levels of transgene,
comparable with those yielded by AdTL-RGD (data not shown).
Highly efficient transduction of fibroblasts with AdTL-RGD
To confirm the luciferase assay data and to determine the
localization of AdTL-RGD-delivered genes, expression of
green fluorescent protein (GFP) was studied using immuno-
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Figure 1 | Optimization of AdTL-RGD titer. Donor kidneys were
infused via the renal artery, with increasing doses of AdTL-RGD
(n¼ 5/group) or saline, incubated at 41C for 20 min, flushed with
saline and then transplanted into syngeneic recipients. Recipient rats
were killed 3 days after transplantation and luciferase activity was
measured in several organs. The best and still graft-targeted
luciferase expression was achieved with 3 109 PFU. LK(tx)¼ left
kidney, transplanted; RK¼ recipient right kidney; PFU¼plaque-
forming units.
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Figure 2 | Time course of AdTL-RGD-delivered gene expression in
the transplanted kidneys. Donor kidneys were treated with
3 109 PFU AdTL-RGD before transplantation. Recipient rats were
killed at 3, 7 or 14 days after transplantation infection (n¼ 5/group)
and luciferase activity was measured in the transplanted kidneys.
Results are presented on a logarithmic scale and expressed as
percentages of luciferase activity at day 3 7s.e.m., amounting to
4.91 10570.78 105 c.p.s./mg protein.
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histochemistry. Consistent with luciferase activity data, a
viral dose-dependent amount of GFP expression was found
in the transplanted-infected kidneys. In all the other organs,
GFP was not detectable (data not shown).
In the transplanted kidneys treated with the optimal
AdTL-RGD titer (3 109 PFU), GFP staining was abundantly
localized in interstitial cells, between the tubules, mainly in
the cortex, and also in the outer medulla and to a lesser
extent in the inner medulla (Figure 4a and b). Approxi-
mately 12% of the glomeruli exhibited staining for GFP
(Figure 4c). No GFP expression was seen in tubular epithelial
cells. Saline-treated kidneys were negative for GFP (Figure
4f). To identify the interstitial cell type, thick kidney sections
were analyzed using confocal microscopy. Reconstructed
three-dimensional images of the transplanted kidney clearly
showed that the GFP signal was localized outside the tubular
structures, in cells morphologically resembling fibroblasts
(Figure 5a and b). Accordingly, double immunofluorescence
for GFP and mouse anti-rat prolyl 4-hydroxylase (rPH), a
marker for fibroblasts, showed colocalization of GFP- and
rPH-expressing cells (Figure 5c). Furthermore, many of the
transduced interstitial fibroblasts were activated fibroblasts,
as shown by the double staining for GFP and mouse anti-a-
smooth muscle actin (a-SMA) (Figure 5d). On the contrary,
neither GFP and ectodermal dysplasia-1(ED-1), marker for
macrophages, nor GFP and rat endothelial cell antigen
(RECA-1), were colocalized (Figure 5e and f), ruling out the
possibility that the infected cells were interstitial macro-
phages or interstitial endothelial cells. In the positive
glomeruli, only a limited number of cells (between 3 and
17 per glomerulus) showed staining for GFP. The majority
(80–90%) of the glomerular cells expressing GFP were
localized in the mesangium, and proved to be mesangial
cells, as shown by the colocalization of GFP and Thy-1
staining in consecutive sections (Figure 6).
In contrast with AdTL-RGD, and in line with luciferase
data, a strongly reduced number of GFP-positive interstitial
cells scattered over the kidney sections was found following
infection with AdTL (Figure 4d and e). GFP-positive
interstitial cells were identified as fibroblasts, using the same
approach as for AdTL-RGD. However, administration of
AdTL resulted in a similar amount and localization of
infected cells in glomeruli (average 12.8%) as found with
AdTL-RGD.
Renal (immuno)histology after transplantation infection
To determine whether AdTL-RGD and AdTL induced any
additional injury in the transplanted kidneys, expression of
a-SMA, an early marker of renal damage, and the presence of
AdTL AdTL-RGD
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Figure 3 | Comparison between transduction efficiency with AdTL
and AdTL-RGD. Donor kidneys (n¼ 5/group) were infused with
3 109 PFU of either AdTL or AdTL-RGD and transplanted in
syngeneic rats. Luciferase activity was measured in the kidney
homogenates 3 days after transplantation infection. Markedly
enhanced luciferase activity was found in the transplanted kidneys
when using AdTL-RGD. *Po0.01.
Figure 4 | Immunohistochemical staining for GFP 3 days after transplantation. Kidneys transduced with AdTL-RGD showed GFP-positive
cells abundantly localized in the interstitium of the cortex (Co) and outer medulla (OM), and to a lesser extent in the inner medulla (IM)
(a, original magnification 40), between the tubules (b, arrows, original magnification 200), and showed GFP-positive glomerulus (c, arrow,
original magnification 400). In contrast, only a few GFP-positive interstitial cells were found in kidneys infused with AdTL (d, e, original
magnification 40 and  200, respectively). Saline-treated kidneys were negative for GFP (f, original magnification 40). Sections were
counterstained with hematoxylin.
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inflammatory cells macrophages (ED-1) and cytotoxic
T lymphocytes (CD8) were evaluated 3, 7 and 14 days after
the procedure and compared to saline treatment. The results
are summarized in Table 1. No difference in the expression
of either interstitial a-SMA or interstitial ED-1 was
found between the saline- and AdTL-infused or AdTL-RGD-
infused kidneys at any time point. However, an increase in
interstitial CD8þ cells was detected in the virus-treated
kidneys (Po0.05 compared to saline), irrespective of virus
modification. Infiltration with CD8þ cells reached a max-
imum at day 7 and decreased thereafter. No immune cell
infiltration (macrophages and cytotoxic lymphocytes) was
present in other organs, including the liver, in animals receiving
a virus-infused kidney (data not shown). This is in line with
luciferase and GFP data, showing an almost complete absence
of transgene expression in organs other than the transplanted
kidney.
DISCUSSION
The present study demonstrates highly efficient and selective
gene transfer to the transplanted kidneys using an adenovirus
that has an RGD motif inserted in the HI loop of the fiber
knob. Employing this strategy, enhanced infectivity of the
adenovirus was achieved, without increasing virus-induced
renal damage. Moreover, to our knowledge, we are the first to
describe efficient transduction of the interstitial fibroblasts in
a model of renal transplantation.
Previous studies have emphasized the superiority of the
adenovirus compared to other vectors available for transduc-
tion of the transplanted kidney (reviewed in Van der Wouden
et al.2). Depending on different parameters of graft perfusion,
Figure 5 | Identification of interstitial cells infected with AdTL-
RGD, using confocal microscopy and double immunofluores-
cence. (a) Three-dimensional image (30 mm thickness) of trans-
planted kidneys transduced with AdTL-RGD, showing fibroblast-like
cells (green, arrows) abundantly localized outside the tubular
structures (red, autofluorescence). (b) Transmission microscopy
providing structural information for panel a. Representative pictures
from double immunofluorescence (3 mm thickness), (c, colocalization,
arrows) showing that the infected cells (GFP, green) were fibroblasts
(rPH, red), (d, colocalization, arrows) many of which were activated
fibroblasts expressing SMA (red). No colocalization was seen for (e)
GFP (green) and macrophages (ED-1, red), (f) nor for GFP (green) and
endothelial cells (RECA-1, red). Bar = 100mm. Gl¼glomerulus,
T¼ tubule.
Figure 6 | Colocalization of GFP with Thy-1 in glomeruli.
Consecutive sections from paraffin-embedded tissue were stained for
GFP and Thy-1, a marker for mesangial cells. (a, black, arrows) Only a
limited number of glomerular cells exhibited GFP staining. (b, black,
arrows) Most of the cells positive for GFP had mesangial cell-like
morphology and showed staining for Thy-1 in consecutive sections.
Original magnification  1000 for both images.
Table 1 | Quantification of immunohistological characteristics
of the transplanted kidneys 3 days after transplantation
infection
Saline (n=4–5/
time point)
AdTL (n=4–5/
time point)
AdTL-RGD (n=5/
time point)
Interstitial a-SMA (% stained area)
Day 3 6.5470.85 4.9170.83 4.0970.73
Day 7 4.2470.90 4.1770.21 3.5670.71
Day 14 2.4070.12 2.3670.21 2.5170.24
Interstitial macrophages (ED-1+ cells)
Day 3 190.8727.7 182.6716.6 179.7712.6
Day 7 146.9711.4 147.578.7 149.0710.6
Day 14 90.5715.8 98.9710.2 82.4713.6
Interstitial cytotoxic T lymphocytes (CD8+ cells)
Day 3 9.570.9 11.970.5* 12.470.7*
Day 7 14.170.5 25.170.7* 23.471.3*
Day 14 11.070.8 17.871.2* 15.170.6*
Data are mean7s.e.m. (*Po0.05 compared with saline-treated kidneys). SMA=
smooth muscle actin.
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such as temperature, time, pressure and viral dose, targeting
to different renal compartments was achieved. However, long
incubation and rather sophisticated perfusion systems were
generally required in order to achieve transgene expression in
the renal graft. In this study, we report a rapid and highly
efficient method to transduce the transplanted kidney
through an RGD-modified adenovirus. Using an intra-
arterial infusion combined with clamping of the renal vein,
followed by 20 min incubation at 41C, we were able to obtain
evenly distributed transgene expression in the cortex and
outer medulla of the renal graft. However, the same amount
of unmodified adenovirus yielded significantly less transgene
expression, as shown by both luciferase activity and GFP
staining. This finding is in line with previous reports,
showing augmented infectivity of the RGD-adenovirus both
in vitro10,11 and in organs other than the kidney, in several
animal models.10–12
Importantly, transgene expression was restricted to the
renal graft. Apparently, it was mainly the specific setting of
transplantation (which allowed us to flush out the viral
solution before transplantation) that counted for selectivity,
as the same tissue distribution pattern was observed for both
adenoviral vectors. The very low levels of luciferase found in
the liver and the spleen were presumably the result of a
limited amount of virus recirculating from the donor kidney
after transplantation.
The targeted cells within the renal graft were mainly
interstitial fibroblasts and a limited number of glomerular
cells. Previous studies that used recombinant adenovirus to
transduce renal graft showed localization of transgene in
proximal13,14 and distal14 tubular epithelial cells, glomeruli15
or blood vessels.16 The exact mechanism of targeting in each
of these studies is not completely elucidated. Targeting of
tubules could be a result of either glomerular filtration or the
passage of adenoviral particles through the peritubular
capillaries, followed by tubular infection. Glomerular trans-
duction could be achieved by prolonged perfusion of the
kidney with viral solution. Blood vessels could be infected
using high pressure and prolonged incubation. Besides,
species differences should also be taken into account when
comparing the results of these studies. It is tempting to
speculate about a mechanism of targeting in our study. Most
likely, during infusion via the renal artery, the virus reaches
and passes glomeruli without being filtered, as we did not see
any transgene expression in the tubules. A limited amount of
virus infects glomerular cells. Most of the virus reaches the
interstitium, probably passing through peritubular capil-
laries. In the interstitium, the interaction between RGD
peptide and the integrins on the surface of fibroblasts17 is
responsible for enhanced infectivity of AdTL-RGD. An
alternative explanation could be that the RGD-adenovirus
(and not the unmodified adenovirus) reaches the interstitium
via the vasa rectae, through interaction with the integrins.
However, as the vasa rectae are localized in the medulla, and
as mostly the cortical area and less the medullar area was
transduced, this pathway seems less plausible, or less
important. Why specifically the fibroblasts were infected in
our study and not other cell types that also express integrins,
such as endothelial cells, is also not entirely clear. Earlier,
McDonald et al.18 observed selective transgene expression in
the renal cortical vasculature when using an RGD insertion in
the C-terminus of the fiber. Differences in infusion
technique, RGD location in the virus19 or the three-
dimensional (circular or linear) structure of the RGD
sequence20 may well explain the distinct targeting in these
two studies.
Interestingly, although the RGD-adenovirus infected the
interstitial fibroblasts much more efficiently than the
unmodified adenovirus, the percentage of infected glomeruli
remained the same. As AdTL-RGD retains the CAR-binding
property, it is likely that CAR expression is a limiting factor
for glomerular transduction, whereas CAR-independent
pathways are more important for transduction of interstitial
fibroblasts. Thus, it seems conceivable that the use of a CAR-
ablated, RGD-modified adenovirus would lead to specific
targeting of interstitial fibroblasts. However, as the overall
number of transduced glomerular cells was rather low, the
use of such a truly re-targeted vector does not seem to be
essentially required for a fibroblast-targeted therapeutic
effect.
Targeting of fibroblasts, as achieved in our study, is of
general importance for designing pathophysiologic and
therapeutic studies regarding progressive renal diseases,
where fibrosis is a common final pathway.21 From previous
attempts to target renal fibroblasts in vivo, only a few
strategies were successful: ureteral injection of hemaggluti-
nating virus of Japan liposomes,22 injection of a large volume
of naked plasmid DNA via the renal vein23 and ureteral
injection of DNA plasmids combined with electroporation.24
However, data on fibroblast transduction in the renal graft
are lacking. For kidney transplantation in particular, target-
ing of the interstitium is important for preventing both
short- and long-term events, as the interstitium is the theater
of both acute rejection and long-term fibrosis. With the first-
generation adenovirus that we used in this study, transgene
expression is short term, due to the immune response elicited
by the virus. However, local expression of immunosupressive
molecules with this vector might not only influence the
rejection of the renal graft, but also inhibit the immune
response against the virus itself, thereby prolonging the
availability of the gene product.25 Most suitable in this
respect would probably be factors acting in a paracrine
fashion, such as immunosuppressive cytokines, which would
be able to modulate the tubulo-interstitial microenvironment
during the first weeks after transplantation.
Proliferation and activation of the interstitial fibroblasts
into a-SMA-expressing myofibroblasts is widely recognized
as a key event in early transplantation-related injury, leading
to fibrosis and ultimately loss of renal graft function.26 Thus,
blockade of early activation of interstitial fibroblasts might
limit long-term fibrosis. In our study, many of the infected
cells were SMA-expressing fibroblasts (myofibroblasts). The
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SMA expression was maximal at days 3–4 and overlapped
with the maximal expression of the transgene. Therefore,
blockade of fibroblast activation seems feasible, through
targeted expression of, for example transforming growth
factor-blocking molecules (such as members of the Smad
family). If extension of expression time is required, the
insertion of the RGD motif in a third-generation (‘gutless’)
adenovirus would be more suitable, as this would allow
prolonged production of the transgene27 in the interstitial
fibroblasts.
Kidney transplantation is associated with marked injury
due to ischemia and reperfusion. First-generation adeno-
virus, as used in our study, elicits both innate and adaptive
immune responses and may also induce renal damage. In our
study, no additional rise in either interstitial SMA expression,
an early marker for renal damage, or macrophage influx was
found in the virus-infused kidneys. However, an increase in
cytotoxic T lymphocytes accompanied the adenoviral infec-
tion. Remarkably, enhanced transduction efficiency of AdTL-
RGD did not further increase the AdTL-induced immune
response, as reflected by the number of CD8þ cells. It is also
noteworthy that the increased number of cytotoxic lympho-
cytes at later time points was not accompanied by additional
renal damage, as evaluated by the amount of SMA
expression, at any time point.
In summary, our current data convincingly show en-
hanced and selective gene transfer to the interstitial
fibroblasts of a rat transplanted kidney with an RGD-
modified adenovirus, allowing further design of local immuno-
suppressive strategies for prevention of acute rejection. For
chronic renal transplant failure, an RGD-‘gutless’ adenovirus
would probably be more suitable for approaching local
immunosuppressive and/or antifibrotic therapeutic strategies.
MATERIALS AND METHODS
Vectors
First-generation recombinant adenovirus type 5 AdTL28 and AdTL-
RGD7 were generously provided by Dr David T Curiel (University of
Alabama at Birmingham, Birmingham, AL, USA). Both adeno-
viruses express GFP (T) and firefly luciferase under the control of a
cytomegalovirus promoter, in the E1 region. The viruses were
isogenic, except for the presence of RGD sequence in the AdTL-
RGD. Adenoviruses were propagated on 293 cells and purified by
double CsCl density centrifugation. The amount of viral particles
was determined spectrophotometrically at 260 nm. The infectivity of
the viruses was determined by plaque assay on 293 cells and
expressed as PFU per milliliter of virus stock (PFU/ml). The viral
particle/PFU ratio of the virus stocks was 100/1.
Experimental model
Inbred male Lewis rats (Lew SsnHsd, Harlan, UK) weighing
200–250 g were used. The animal experimental protocols were
approved by the Animal Research Ethics Committee of the
University of Groningen, The Netherlands. Experiments were
performed in a rat Lewis-to-Lewis kidney transplantation model.
In the donor rat, the aorta was clamped between the renal pedicles
and above the bifurcation, and the left kidney was then perfused in
situ with saline, followed by infusion of 0.4 ml of viral solution. At
the time of infusion, the renal vein was clamped. At the end of
infusion, the renal artery was also clamped and the kidney was
stored in saline on ice for 20 min. The kidney was then slowly
perfused with saline and transplanted orthotopically into a
syngeneic animal, as previously described.29 Warm ischemia time
was 25 min. The right native kidney was left inside until the time the
animal was killed.
In a first series of experiments, the optimal titer of AdTL-RGD
for transduction of the transplanted kidney was determined.
Animals were randomly divided into five groups (n¼ 5 trans-
planted animals/group) that received saline or 0.8 109, 1.5 109,
3 109 and 6 109 PFU, respectively. After 3 days, the rats were
killed and the kidneys as well as the liver, brain, heart, lungs, spleen,
gut and testis were removed and processed for luciferase assay,
confocal microscopy and immunohistology. Secondly, the time
course of reporter gene expression was studied, with animals being
treated with the optimal AdTL-RGD titer. Two groups of animals
(n¼ 5/group) were killed at days 7 and 14, and the organs were
analyzed for luciferase activity. Thirdly, the suitability of AdTL-
RGD-mediated gene delivery for renal transplantation was
compared with that of an unmodified AdTL (n¼ 4–5/group). For
this purpose, efficiency, tissue distribution and side effects were
studied at days 3, 7 and 14 after transplantation. Rats that received
kidneys infused with saline (n¼ 4–5/time point) were included as
controls.
At the time the animals were killed, the whole body was perfused
with saline and various organs were collected. One half of each
organ was prepared for luciferase assay. From the other half,
two slices were obtained. For confocal microscopy, one slice was
fixed in paraformaldehyde–sucrose, as previously described.30 For
immunohistochemistry and immunofluorescence, the other slice
was processed for paraffin embedding.
Luciferase activity assay
The luciferase activity after transduction with either AdTL-RGD or
AdTL was measured using a luciferase assay kit (Luciferase Assay
System, Promega Corporation, Madison, WI), according to the
manufacturer’s recommendations. Briefly, the tissue was homo-
genized in lysis buffer, incubated on ice for 1 h and centrifuged at
41C. For luminometry, 10 ml of supernatant was added to 50ml
luciferase assay reagent and the emitted light was immediately
measured using a Wallac Victor2 (Turku, Finland) luminometer.
Results are expressed as counts per second/milligram protein.
Protein concentration was determined by a Bradford protein assay,
using bovine serum albumin as standard.
Confocal microscopy
Cells infected with GFP-expressing adenoviruses were visualized
with an LSM 410 laser scanning microscope (Carl Zeiss, Jena,
Germany). Confocal images of GFP fluorescence were collected
using 488-nm excitation light from a two-line argon laser and a
510–525 nm band-pass filter. Simultaneously, structural information
about the kidney was obtained by detection of autofluorescence at
emission wavelengths higher than 570 nm. Three-dimensional
information of thick tissue sections (40–60 mm) of paraformaldehy-
de–sucrose-fixed tissue was obtained from a stack of 30 optical
sections representing 30 mm thickness.
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Immunohistochemistry and immunofluorescence
To localize the transgene expression, a GFP immunostaining was
performed using a rabbit anti-GFP antibody (Molecular Probes,
Leiden, The Netherlands). To identify the infected cells, additional
double immunostainings were performed, using markers for
fibroblasts rPH (Acris Antibodies, Hiddenhausen, Germany), activated
fibroblasts a-SMA (Sigma Chemical Co, St Louis, MO), macrophages
(mouse anti-ED-1, Serotec Ltd, Oxford, UK), endothelial cells
(mouse anti-RECA-1, generously provided by Professor G Molema,
University Medical Center, Groningen, The Netherlands) and
mesangial cells (mouse anti-Thy-1, a kind gift from Dr WW Bakker,
University Medical Center, Groningen, The Netherlands). To evaluate
the renal damage after the transplantation-infection procedure,
sections were stained for SMA, macrophages (ED-1) and cytotoxic
T lymphocytes (mouse anti-CD8, kindly provided by Dr JL
Hillebrand, University Medical Center Groningen, The Netherlands).
Before the immunostaining procedure, paraffin sections (3mm)
were dewaxed and subjected to antigen retrieval by microwave-
induced heat in 0.1 M Tris/HCl, pH 9.0 (GFP) or in 1 mM EDTA
buffer, pH 8.0 (CD8), and overnight incubation in 0.1 M Tris/HCl
buffer, pH 9.0, at 801C (a-SMA, ED-1) or 0.1% protease (Thy-1).
For immunohistochemistry, a two-step immunoperoxidase
technique was used, according to standard methods, as previously
described.31 Peroxidase activity was developed using 30,30-diamino-
benzidine tetrachloride and H2O2. For double immunofluorescence,
sections were incubated with primary antibodies (GFP and rPH,
a-SMA, ED-1 or RECA-1), followed by fluorescein isothiocyanate-
conjugated goat anti-rabbit and tetramethyl rhodamine isothio-
cyanate (TRITC)-conjugated goat anti-mouse antibodies. Green
(GFP) and red (rPH, SMA, ED-1 or RECA-1) fluorescent signals
were visualized using confocal microscopy.
Morphometry
The number of glomeruli positive for GFP immunostaining was
counted in 10 optical fields at  100 magnification. A glomerulus
was considered positive if at least three cells showed GFP staining.
The expressions of a-SMA and ED-1 were measured using
computer-assisted morphometry. A total of 30 (a-SMA) or 40
(ED-1) fields were evaluated at a magnification of  200. For a-SMA,
the total staining was divided by the area measured, and expressed as
a percentage. For ED-1, the number of positive cells per area was
measured. An average score was calculated per section. CD8-positive
cells were counted in 30 fields using an ocular grid at  400
magnification and expressed as an average per field.
Statistics
Results are presented as mean7s.e.m. Statistical analyses were
performed using ANOVA and Student–Newman–Keuls test. Differ-
ences were considered significant at Po0.05.
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